Hormonal & Reproductive Health
Founded 1863
Sells To Consumers, Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public

Bayer's Hormonal & Reproductive Health area covers contraception, menopause, endometriosis and related women's health therapies.
Hormonal & Reproductive Health is a treatment area within Bayer's Pharmaceuticals division addressing conditions that affect women across their lives, from contraception and heavy menstrual bleeding to menopause, endometriosis and myomas.
The portfolio is organized around patient needs in contraception, heavy menstrual bleeding, menopause, endometriosis and acne therapy, and sits alongside Bayer's women's health access initiatives, including family planning programs.
| Attribute | Hormonal & Reproductive Health | Women's Health | |
|---|---|---|---|
| Provider | |||
| Founded | 1863 | 2003 | |
| Sells To | Consumers, Enterprise | — | |
| Pricing Model | Recurring, Software, Transactional | — | |
| Ownership | Public | — |
Founded 1863
Sells To Consumers, Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded 2003
Sells To —
Pricing Model —
Ownership —


Organon's Women's Health portfolio addresses contraception, fertility, menopause and other women's health conditions across more than 140 markets.


Women's healthcare portfolio spanning contraception, fertility, menopause, and related conditions.


Women's health portfolio spanning contraceptives, hormone therapy, and prenatal supplements.
Organon's Women's Health portfolio addresses contraception, fertility, menopause and other women's health conditions across more than 140 markets.

Women's healthcare portfolio spanning contraception, fertility, menopause, and related conditions.

Women's health portfolio spanning contraceptives, hormone therapy, and prenatal supplements.
